Terrence K Pleasant Jr, MD in Ann Arbor, MI - Medicare Otolaryngology

Terrence K Pleasant Jr, MD is a medicare enrolled "Otolaryngology - Pediatric Otolaryngology" physician in Ann Arbor, Michigan. His current practice location is 1500 E Medical Center Dr, Ann Arbor, Michigan. You can reach out to his office (for appointments etc.) via phone at (734) 936-4000.

Terrence K Pleasant Jr is licensed to practice in Michigan (license number 4301507703) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1205285749.

Contact Information

	Terrence K Pleasant Jr, MD
	1500 E Medical Center Dr, Ann Arbor, MI 48109-5000
	(734) 936-4000
	Not Available

Physician's Profile

Full Name	Terrence K Pleasant Jr
Gender	Male
Speciality	Otolaryngology - Pediatric Otolaryngology
Location	1500 E Medical Center Dr, Ann Arbor, Michigan
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1205285749
Provider Enumeration Date: 06/06/2016
Last Update Date: 09/15/2023

Medicare PECOS Information:

PECOS PAC ID: 8921398439
Enrollment ID: I20220913003014

Medical Identifiers

Medical identifiers for Terrence K Pleasant Jr such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1205285749	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	4301507703 (Michigan)	Secondary
207YP0228X	Otolaryngology - Pediatric Otolaryngology	4301507703 (Michigan)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Terrence K Pleasant Jr allows following entities to bill medicare on his behalf.

Entity Name	Regents Of The University Of Michigan
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325

News Archive

Novelos Therapeutics commences enrollment in Phase 2 trial of NOV-205 for chronic hepatitis C

Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that it has enrolled the first patient in a U.S. Phase 2 trial evaluating NOV-205 as monotherapy in up to 40 chronic hepatitis C genotype 1 patients who previously failed treatment with pegylated interferon plus ribavirin.

Decreased synaptic gain in people diagnosed with schizophrenia

Schizophrenia, which can cause disrupted thought and mood, delusions and hallucinations, is among the most debilitating mental disorders and the most mysterious.

Skinvisible granted Japanese patent for Invisicare

Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'

UH researchers create Walk n' Play iPhone application to keep track of physical activity

An iPhone application created by UH researchers is providing first-of-its-kind real-time statistics of physical activity around the world. Those annual rankings of America's fattest and fittest cities that use government statistics and a host of indirect indicators may soon have a little more muscle. The information being collected at the University of Houston provides objective data.

SATAI invests $1.045 million in Azaya Therapeutics

SATAI (www.satai.us) and the South Texas Regional Center of Innovation and Commercialization (www.strcic.com) today announced an investment of $1.045 million in Azaya Therapeutics, Inc. through the Texas Emerging Technology Fund (ETF) for the commercialization of Azaya's proprietary Protein Stabilized Nanoparticle (PSN) technology platform to produce targeted, safer and more effective formulations of chemotherapy pharmaceuticals for the treatment of cancer.

Novelos Therapeutics commences enrollment in Phase 2 trial of NOV-205 for chronic hepatitis C

Decreased synaptic gain in people diagnosed with schizophrenia

Schizophrenia, which can cause disrupted thought and mood, delusions and hallucinations, is among the most debilitating mental disorders and the most mysterious.

Skinvisible granted Japanese patent for Invisicare

UH researchers create Walk n' Play iPhone application to keep track of physical activity

SATAI invests $1.045 million in Azaya Therapeutics

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Terrence K Pleasant Jr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Terrence K Pleasant Jr, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299	Terrence K Pleasant Jr, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000

News Archive

Novelos Therapeutics commences enrollment in Phase 2 trial of NOV-205 for chronic hepatitis C

Decreased synaptic gain in people diagnosed with schizophrenia

Schizophrenia, which can cause disrupted thought and mood, delusions and hallucinations, is among the most debilitating mental disorders and the most mysterious.

Skinvisible granted Japanese patent for Invisicare

UH researchers create Walk n' Play iPhone application to keep track of physical activity

SATAI invests $1.045 million in Azaya Therapeutics

Otolaryngology Doctors in Ann Arbor, MI

Jeffrey John Stanley, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000
Dr. Erin Lynn Mckean, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000
Susan L Garetz, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, 2nd Floor Taubman Cter Recp G, Ann Arbor, MI 48109 Phone: 734-936-5730
Jeffrey Scott Moyer, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000
Amarbir Singh Gill, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000
Natalie S Justicz, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000
Dr. Robert Harris Gilman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 24 Frank Lloyd Wright Dr, Ann Arbor, MI 48105 Phone: 734-998-6022 Fax: 734-998-9139

Terrence K Pleasant Jr, MD - Medicare Otolaryngology in Ann Arbor, MI

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Novelos Therapeutics commences enrollment in Phase 2 trial of NOV-205 for chronic hepatitis C

Decreased synaptic gain in people diagnosed with schizophrenia

Skinvisible granted Japanese patent for Invisicare

UH researchers create Walk n' Play iPhone application to keep track of physical activity

SATAI invests $1.045 million in Azaya Therapeutics

Novelos Therapeutics commences enrollment in Phase 2 trial of NOV-205 for chronic hepatitis C

Decreased synaptic gain in people diagnosed with schizophrenia

Skinvisible granted Japanese patent for Invisicare

UH researchers create Walk n' Play iPhone application to keep track of physical activity

SATAI invests $1.045 million in Azaya Therapeutics

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Novelos Therapeutics commences enrollment in Phase 2 trial of NOV-205 for chronic hepatitis C

Decreased synaptic gain in people diagnosed with schizophrenia

Skinvisible granted Japanese patent for Invisicare

UH researchers create Walk n' Play iPhone application to keep track of physical activity

SATAI invests $1.045 million in Azaya Therapeutics

Otolaryngology Doctors in Ann Arbor, MI